{
    "status": "ok",
    "totalResults": 6,
    "articles": [
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "PRNewswire",
            "title": "IceCure Medical Receives FDA Response to De Novo Classification Request for Breast Cancer",
            "description": "(marketscreener.com) \n\nCAESAREA, Israel, Sept. 20, 2023 /PRNewswire/ --\u00a0IceCure Medical Ltd. , developer of the ProSense\u00ae System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today \u2026",
            "url": "https://www.marketscreener.com/quote/stock/ICECURE-MEDICAL-LTD-120795404/news/IceCure-Medical-Receives-FDA-Response-to-De-Novo-Classification-Request-for-Breast-Cancer-44884498/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-09-20T11:01:10Z",
            "content": "CAESAREA, Israel, Sept. 20, 2023 /PRNewswire/ --\u00a0IceCure Medical Ltd. (Nasdaq: ICCM), developer of the ProSense\u00ae System, a minimally-invasive cryoablation technology that destroys tumors by freezing \u2026 [+7341 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "PRNewswire",
            "title": "Renowned Spanish Radiologist Luc\u00eda Gra\u00f1a-L\u00f3pez to Present Data Using IceCure Medical's ProSense at European Society of Breast Imaging Scientific Meeting 2023",
            "description": "(marketscreener.com) \n\nGrowing body of evidence-based data is giving women a minimally invasive alternative to the standard of care lumpectomyPatients throughout the European Union have access to\u00a0ProSense for the treatment of malignant and benign breast tumor\u2026",
            "url": "https://www.marketscreener.com/quote/stock/ICECURE-MEDICAL-LTD-120795404/news/Renowned-Spanish-Radiologist-Luc-a-Gra-a-L-pez-to-Present-Data-Using-IceCure-Medical-s-ProSense-at-E-44904774/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
            "publishedAt": "2023-09-22T12:01:07Z",
            "content": "<ul><li>Growing body of evidence-based data is giving women a minimally invasive alternative to the standard of care lumpectomy</li><li>Patients throughout the European Union have access to\u00a0ProSense \u2026 [+4981 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Biztoc.com"
            },
            "author": "benzinga.com",
            "title": "Why Is Breast Cancer Diagnostic Focused IceCure Medical Stock Trading Higher Today?",
            "description": "IceCure Medical Ltd ICCM announced that new data was presented at the European Society of Breast Imaging Scientific Meeting, validating IceCure's ProSense Cryoablation is a safe and effective outpatient procedure for breast cancer with a 96.8% success rate. T\u2026",
            "url": "https://biztoc.com/x/4ebd6606ea9f1b39",
            "urlToImage": "https://c.biztoc.com/p/4ebd6606ea9f1b39/s.webp",
            "publishedAt": "2023-10-02T16:00:07Z",
            "content": "IceCure Medical Ltd ICCM announced that new data was presented at the European Society of Breast Imaging Scientific Meeting, validating IceCure's ProSense Cryoablation is a safe and effective outpati\u2026 [+293 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PRNewswire"
            },
            "author": null,
            "title": "Renowned Spanish Radiologist Luc\u00eda Gra\u00f1a-L\u00f3pez to Present Data Using IceCure Medical's ProSense at European Society of Breast Imaging Scientific Meeting 2023",
            "description": "Growing body of evidence-based data is giving women a minimally invasive alternative to the standard of care lumpectomy Patients throughout the European Union have access to ProSense for the treatment of malignant and benign breast tumors CAESAREA, Israel, Se\u2026",
            "url": "https://www.prnewswire.com/news-releases/renowned-spanish-radiologist-lucia-grana-lopez-to-present-data-using-icecure-medicals-prosense-at-european-society-of-breast-imaging-scientific-meeting-2023-301935547.html",
            "urlToImage": "https://mma.prnewswire.com/media/1941429/IceCure_Logo.jpg?p=facebook",
            "publishedAt": "2023-09-22T12:00:00Z",
            "content": "<ul><li>Growing body of evidence-based data is giving women a minimally invasive alternative to the standard of care lumpectomy</li><li>Patients throughout the European Union have access to\u00a0ProSense \u2026 [+4732 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Salesandmarketingnetwork.com"
            },
            "author": "IceCure Medical",
            "title": "IceCure Medical Receives FDA Response to De Novo Classification Request for Breast Cancer",
            "description": "CAESAREA, Israel, Sept. 20, 2023 -- (Healthcare Sales & Marketing Network) -- IceCure Medical Ltd. (Nasdaq: ICCM), developer of the ProSense\u00ae System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to su... Devi\u2026",
            "url": "https://salesandmarketingnetwork.com/news_release_bs.html?ID=2048088",
            "urlToImage": null,
            "publishedAt": "2023-09-20T12:56:13Z",
            "content": "CAESAREA, Israel, Sept. 20, 2023 -- (Healthcare Sales &amp; Marketing Network) -- IceCure Medical Ltd. (Nasdaq: ICCM), developer of the ProSense System, a minimally-invasive cryoablation technology t\u2026 [+7116 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PRNewswire"
            },
            "author": null,
            "title": "IceCure Medical Receives FDA Response to De Novo Classification Request for Breast Cancer",
            "description": "CAESAREA, Israel, Sept. 20, 2023 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM), developer of the ProSense\u00ae System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced\u2026",
            "url": "https://www.prnewswire.com/news-releases/icecure-medical-receives-fda-response-to-de-novo-classification-request-for-breast-cancer-301933082.html",
            "urlToImage": "https://mma.prnewswire.com/media/1941429/IceCure_Logo.jpg?p=facebook",
            "publishedAt": "2023-09-20T11:00:00Z",
            "content": "CAESAREA, Israel, Sept. 20, 2023 /PRNewswire/ --\u00a0IceCure Medical Ltd. (Nasdaq: ICCM), developer of the ProSense\u00ae System, a minimally-invasive cryoablation technology that destroys tumors by freezing \u2026 [+7159 chars]"
        }
    ]
}